Total Payments
$2,767
2024 Payments
$361.61
Companies
23
Transactions
156
Medicare Patients
4,166
Medicare Billing
$485,449
Payment Breakdown by Category
Food & Beverage$2,767 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,767 | 156 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,279 | 72 | $0 (2024) |
| Janssen Biotech, Inc. | $456.96 | 34 | $0 (2023) |
| Madrigal Pharmaceuticals | $145.43 | 1 | $0 (2024) |
| PFIZER INC. | $124.85 | 8 | $0 (2023) |
| Echosens North America, Inc. | $115.85 | 1 | $0 (2019) |
| BioFire Diagnostics, LLC | $68.05 | 1 | $0 (2019) |
| Braintree Laboratories, Inc. | $66.17 | 5 | $0 (2022) |
| Gilead Sciences, Inc. | $65.06 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $60.25 | 5 | $0 (2021) |
| Allergan Inc. | $58.38 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $361.61 | 13 | ABBVIE INC. ($152.76) |
| 2023 | $261.68 | 15 | AbbVie Inc. ($150.61) |
| 2022 | $246.66 | 13 | ABBVIE INC. ($183.71) |
| 2021 | $630.23 | 34 | AbbVie Inc. ($386.15) |
| 2020 | $114.44 | 7 | AbbVie Inc. ($73.47) |
| 2019 | $356.28 | 16 | Echosens North America, Inc. ($115.85) |
| 2018 | $383.13 | 32 | AbbVie, Inc. ($134.25) |
| 2017 | $413.09 | 26 | AbbVie, Inc. ($173.23) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $145.43 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.18 | General |
| 08/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.43 | General |
| Category: Neuroscience | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.81 | General |
| Category: Neuroscience | ||||||
| 06/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Immunology | ||||||
| 10/30/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/18/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immunology | ||||||
| 10/05/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Immunology | ||||||
| 09/05/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2023 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,033 | 1,199 | $785,690 | $130,623 |
| 2022 | 15 | 1,101 | 1,239 | $723,370 | $127,737 |
| 2021 | 11 | 1,036 | 1,213 | $665,306 | $120,392 |
| 2020 | 15 | 996 | 1,141 | $494,222 | $106,697 |
Total Patients
4,166
Total Services
4,792
Medicare Billing
$485,449
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 200 | 203 | $225,330 | $44,775 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 266 | 423 | $169,200 | $28,398 | 16.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 211 | 212 | $152,240 | $16,834 | 11.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 135 | 135 | $64,660 | $9,634 | 14.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $52,920 | $8,618 | 16.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 12 | $46,440 | $7,699 | 16.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 24 | 24 | $19,440 | $4,415 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 41 | $23,370 | $4,157 | 17.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $10,530 | $2,501 | 23.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $11,340 | $1,958 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $10,220 | $1,634 | 16.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 157 | 157 | $174,270 | $33,655 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 255 | 364 | $145,600 | $24,873 | 17.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 203 | 204 | $140,360 | $20,439 | 14.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 156 | 158 | $65,880 | $11,760 | 17.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 129 | 129 | $63,210 | $10,465 | 16.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 47 | 50 | $29,000 | $5,570 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 49 | $27,930 | $4,964 | 17.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $21,060 | $4,892 | 23.2% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 15 | $11,310 | $2,396 | 21.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $9,720 | $2,283 | 23.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $10,530 | $1,735 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $8,030 | $1,525 | 19.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 24 | $7,440 | $1,432 | 19.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 12 | $6,480 | $1,260 | 19.4% |
About Dr. Thomas Simcox, MD
Dr. Thomas Simcox, MD is a Gastroenterology healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1124287461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Simcox, MD has received a total of $2,767 in payments from pharmaceutical and medical device companies, with $361.61 received in 2024. These payments were reported across 156 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,767).
As a Medicare-enrolled provider, Simcox has provided services to 4,166 Medicare beneficiaries, totaling 4,792 services with total Medicare billing of $485,449. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Annapolis, MD
- Active Since 06/02/2008
- Last Updated 09/23/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124287461
Products in Payments
- HUMIRA (Biological) $457.95
- STELARA (Biological) $440.53
- Humira (Biological) $295.41
- SKYRIZI (Biological) $198.41
- REZDIFFRA (Drug) $145.43
- LINZESS (Drug) $120.98
- FibroScan (Device) $115.85
- RINVOQ (Biological) $102.44
- XELJANZ (Drug) $100.61
- CREON (Drug) $82.54
- BioFire FilmArray (Device) $68.05
- VIBERZI (Drug) $53.54
- OCALIVA (Drug) $45.79
- SUTAB (Drug) $45.26
- ZEPOSIA (Drug) $44.24
- INJECTAFER (Drug) $29.65
- Trulance (Drug) $25.19
- SUPREP (Drug) $20.91
- SUCRAID (Drug) $20.36
- ENTYVIO (Biological) $19.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Annapolis
Dr. Michael Epstein, M.d, M.D
Gastroenterology — Payments: $644,789
Gastroenterology $644,789
Dr. Raja Taunk, M.d, M.D
Gastroenterology — Payments: $347,396
Gastroenterology $347,396
Dr. Mark Flasar, M.d, M.D
Gastroenterology — Payments: $155,798
Gastroenterology $155,798
Dr. Kevin Wolov, D.o, D.O
Gastroenterology — Payments: $31,103
Gastroenterology $31,103
Dr. Vishnupriya Krishna, Md, MD
Gastroenterology — Payments: $17,302
Gastroenterology $17,302
Dr. Charles King, M.d, M.D
Gastroenterology — Payments: $7,579
Gastroenterology $7,579